Cortex Pharmaceuticals, Inc.’s AMPAKINE® Research in Opioid–induced Respiratory Depression Makes Windhover Information Inc.’s Top 10 List of Neuroscience Projects Available for Partnering

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) announced that Mark Varney, Ph.D., President & CEO, will present at the Windhover Information’s 3rd Annual Therapeutic Area Partnerships conference to be held at the Loews Philadelphia Hotel on November 3-5, 2008.